Eli Lilly, under pressure from Biohaven, launches head-to-head migraine trial between Emgality and Nurtec

Eli Lilly, under pressure from Biohaven, launches head-to-head migraine trial between Emgality and NurtecaliuThu, 11/18/2021 - 11:24